GZ402668 / Sanofi  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GZ402668 / Sanofi
NCT02313285: A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668

Completed
N/A
64
Europe
Genzyme, a Sanofi Company
Progressive Multiple Sclerosis
04/22
04/22

Download Options